Zhejiang Huahai Pharmaceutical Co Ltd Sustainability Reports
The company is primarily engaged in the research, development, production, and sales of generic drugs, biological drugs, and active pharmaceutical ingredients (APIs).
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
LEI: 300300A5ITVN4JK5AS34
FIGI: BBG001SKX3L6
3 reports from 2020 to 2025